First LCBL Treatment to Improve Upon Standard of Care in Nearly 30 Years Landmark ZUMA-7 Study Demonstrated Patients on YESCARTA Were 2.5 Times More Likely to Be Alive at 18-months… Read More
OTTAWA, ON — BioTalent Canada celebrates the National Day of Work-Integrated Learning (WIL), today, by releasing the impacts of their student work experiences – through the Student Work Placement Program… Read More
VANCOUVER, BC & LONDON, UK — (BUSINESS WIRE) — AbCellera (Nasdaq: ABCL) and RQ Bio announced today that they have entered into a strategic collaboration to identify optimal clinical candidates for up to… Read More
LONDON, ON — Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical- stage company and leader in cell therapeutics, is pleased to announce that an abstract has been selected for an oral… Read More
TORONTO, ON — /CNW/ — sanofi-aventis Canada Inc. (Sanofi Canada) is pleased to announce that Health Canada has issued a Notice of Compliance (“NOC”) for Rezurock™ (belumosudil tablets), for the… Read More
